The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Promega sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Promega Corp (Promega) is a biotechnology company that offers solutions and technical services to the life science industries in academic, industrial and government sectors. It offers products for cell biology, DNA analysis, drug development, human identification and forensics, instrumentation and labware, molecular diagnostics, protein analysis, and RNA analysis. It also provides services such as custom product dispensing and formulation, custom manufacturing, assay development, cGMP manufacturing, collaborative onsite services, and target deconvolution services, and others. Promega’s products find application in biobanking, clinical research and diagnostics, applied sciences, and water testing, among others. Promega is headquartered in Madison, Wisconsin, the United States. Key subsidiaries of Promega include Promega Benelux, Promega Biosciences, Promega Biotech Iberica, Shanghai Promega Biological Products and Promega BioSystems Sunnyvale.
The key metrics of Promega related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Promega is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Promega.
For a detailed understanding of the performance of Promega, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
